Difference between revisions of "Developmental Signals - Anti-Mullerian Hormone"
|Line 90:||Line 90:|
Revision as of 14:33, 1 June 2018
|Embryology - 29 Nov 2021 Expand to Translate|
|Google Translate - select your language from the list shown below (this will open a new external page)|
العربية | català | 中文 | 中國傳統的 | français | Deutsche | עִברִית | हिंदी | bahasa Indonesia | italiano | 日本語 | 한국어 | မြန်မာ | Pilipino | Polskie | português | ਪੰਜਾਬੀ ਦੇ | Română | русский | Español | Swahili | Svensk | ไทย | Türkçe | اردو | ייִדיש | Tiếng Việt These external translations are automated and may not be accurate. (More? About Translations)
Anti-Mullerian Hormone (AMH; Anti-Müllerian Hormone; Mullerian Inhibiting Substance, MIS; Mullerian Inhibiting Factor, MIF) is a secreted glycoprotein factor (transforming growth factor-beta, TGF-beta superfamily) that regulates gonadal and genital tract development. In the male embryo, the Sertoli cell secrete AMH and inhibit paramesonephric (Mullerian) duct development. In postnatal males, AMH increases during the first month, reaching peak level at 6 months of age, and then slowly declines during childhood falling to low levels in puberty.
In reproductive age women, AMH is produced in the ovary by the granulosa cell surrounding preantral and small antral follicles and serum levels may reflect the remaining follicle cohort and decrease with age.
|Factor Links: AMH | hCG | BMP | sonic hedgehog | bHLH | HOX | FGF | FOX | Hippo | LIM | Nanog | NGF | Nodal | Notch | PAX | retinoic acid | SIX | Slit2/Robo1 | SOX | TBX | TGF-beta | VEGF | WNT | Category:Molecular|
Some Recent Findings
|More recent papers|
This table allows an automated computer search of the external PubMed database using the listed "Search term" text link.
Search term: Anti-Mullerian Hormone
<pubmed limit=5>Anti-Mullerian Hormone</pubmed>
- cytogenetic location - 19p13.3
- human gene has 5 exons
- Secreted protein
- 560 amino acid polypeptide
- C-terminal domain homology with human transforming growth factor-beta and the beta chain of porcine inhibin
- Links: UniProt
AMH can inhibit the autophosphorylation of the Epidermal Growth Factor Receptor (EGFR) in vitro even though it does not compete with EGF for receptor binding sites.
Persistent Müllerian Duct Syndrome
About 85% of all Persistent Müllerian Duct Syndrome (PMDS) cases are due to gene mutations in anti-Müllerian hormone (AMH) or the receptor (AMHR2) with autosomal recessive transmission. Often incidentally diagnosed during surgical repair of inguinal hernia or cryptorchidism.
Polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) has been suggested to involve an over-expression of AMH in the PCOS granulosa cells.
- Sathyapalan T, Al-Qaissi A, Kilpatrick ES, Dargham SR, Keevil B & Atkin SL. (2018). Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome. Sci Rep , 8, 3795. PMID: 29491484 DOI.
- Bertoldo MJ, Walters KA, Ledger WL, Gilchrist RB, Mermillod P & Locatelli Y. (2018). In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies. Reprod. Biomed. Online , , . PMID: 29503209 DOI.
- Elias-Assad G, Elias M, Kanety H, Pressman A & Tenenbaum-Rakover Y. (2016). Persistent Müllerian Duct Syndrome Caused by a Novel Mutation of an Anti-MüIlerian Hormone Receptor Gene: Case Presentation and Literature Review. Pediatr Endocrinol Rev , 13, 731-40. PMID: 27464416
- Stracquadanio M, Ciotta L & Palumbo MA. (2018). Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women. Gynecol. Endocrinol. , 34, 223-228. PMID: 28944702 DOI.
Roly ZY, Backhouse B, Cutting A, Tan TY, Sinclair AH, Ayers KL, Major AT & Smith CA. (2018). The cell biology and molecular genetics of Müllerian duct development. Wiley Interdiscip Rev Dev Biol , , . PMID: 29350886 DOI.
Mossa F, Jimenez-Krassel F, Scheetz D, Weber-Nielsen M, Evans ACO & Ireland JJ. (2017). Anti-Müllerian Hormone (AMH) and fertility management in agricultural species. Reproduction , 154, R1-R11. PMID: 28356501 DOI.
Elias-Assad G, Elias M, Kanety H, Pressman A & Tenenbaum-Rakover Y. (2016). Persistent Müllerian Duct Syndrome Caused by a Novel Mutation of an Anti-MüIlerian Hormone Receptor Gene: Case Presentation and Literature Review. Pediatr Endocrinol Rev , 13, 731-40. PMID: 27464416
Josso N, di Clemente N & Gouédard L. (2001). Anti-Müllerian hormone and its receptors. Mol. Cell. Endocrinol. , 179, 25-32. PMID: 11420127
Kissell KA, Danaher MR, Schisterman EF, Wactawski-Wende J, Ahrens KA, Schliep K, Perkins NJ, Sjaarda L, Weck J & Mumford SL. (2014). Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum. Reprod. , 29, 1764-72. PMID: 24925522 DOI.
Search Bookshelf: Anti-Mullerian Hormone
External Links Notice - The dynamic nature of the internet may mean that some of these listed links may no longer function. If the link no longer works search the web with the link text or name. Links to any external commercial sites are provided for information purposes only and should never be considered an endorsement. UNSW Embryology is provided as an educational resource with no clinical information or commercial affiliation.
- Glossary: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Numbers | Symbols | Term Link
Cite this page: Hill, M.A. (2021, November 29) Embryology Developmental Signals - Anti-Mullerian Hormone. Retrieved from https://embryology.med.unsw.edu.au/embryology/index.php/Developmental_Signals_-_Anti-Mullerian_Hormone
- © Dr Mark Hill 2021, UNSW Embryology ISBN: 978 0 7334 2609 4 - UNSW CRICOS Provider Code No. 00098G